Medivir

1.90 SEK

-1.24%

Less than 1K followers

MVIR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Medivir

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue0.91.03.50.61.50.95.58.5
EBITDA-35.1-26.2-124.6-12.6-22.5-12.9-12.0-60.1
EBIT-35.7-26.9-127.3-13.3-23.2-13.6-42.5-92.6
EBIT-%-3,966.7 %-2,690.0 %-3,637.1 %-2,216.7 %-1,546.7 %-1,511.1 %-772.7 %-1,089.4 %
Profit before taxes-34.6-26.7-123.3-13.3-23.3-14.6-43.2-94.4
Net income-34.6-26.7-123.3-13.3-23.3-14.6-43.2-94.4